Cargando…
Use of Benzodiazepines and Z-Drugs in Multiple Sclerosis
OBJECTIVE: Use of benzodiazepines and Z-drugs (non-benzodiazepine sedative hypnotics) is controversial due to adverse health outcomes in the general population. However, little is known about their use in people with multiple sclerosis (MS). We estimated the incidence and prevalence of benzodiazepin...
Autores principales: | Marrie, Ruth Ann, Fisk, John D., Walld, Randy, Bolton, James M., Sareen, Jitender, Patten, Scott B., Singer, Alexander, Lix, Lisa M., Hitchon, Carol A., El-Gabalawy, Renée, Katz, Alan, Marriott, James J., Bernstein, Charles N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9049992/ https://www.ncbi.nlm.nih.gov/pubmed/35493810 http://dx.doi.org/10.3389/fneur.2022.874724 |
Ejemplares similares
-
Prescription opioid use in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2023) -
Effect of mood and anxiety disorders on health care utilization in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2020) -
Uptake of influenza vaccination among persons with inflammatory bowel disease, multiple sclerosis or rheumatoid arthritis: a population-based matched cohort study
por: Marrie, Ruth Ann, et al.
Publicado: (2021) -
Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data
por: Marrie, Ruth Ann, et al.
Publicado: (2017) -
Effect of comorbid mood and anxiety disorders on breast and cervical cancer screening in immune-mediated inflammatory disease
por: Marrie, Ruth Ann, et al.
Publicado: (2021)